<!DOCTYPE html>
<html lang="it">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Analisi Economica e Benchmark - FLC HEALTHY EVOLUTION S.R.L. | SCAN V9</title>
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.3.0/css/bootstrap.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Titillium+Web:wght@300;400;600;700&display=swap" rel="stylesheet">
    <link href="../css/styles.css" rel="stylesheet">
    <link href="../css/print.css" rel="stylesheet" media="print">
     <style>
        .table-success-light { background-color: #d1e7dd !important; }
        .table-warning-light { background-color: #fff3cd !important; }
        .table-danger-light { background-color: #f8d7da !important; }
     </style>
</head>
<body>

 <!-- Sidebar -->
    <aside class="sidebar no-print">
        <div class="sidebar-header"> <img src="../assets/img/logo_scan.png" alt="SCAN Logo" style="max-height: 40px;"> <h5>FLC HEALTHY EVOLUTION S.R.L.</h5> </div>
        <ul class="sidebar-nav flex-grow-1">
            <li class="nav-item"> <a class="nav-link" href="../dashboard_v2.html"> <i class="fas fa-tachometer-alt fa-fw"></i> Dashboard </a> </li>
            <li class="nav-title">Analisi Dettagliata</li>
            <li class="nav-item"> <a class="nav-link" href="parte1_sintesi.html"> <i class="fas fa-file-alt fa-fw"></i> Sintesi e Profilo </a> </li>
            <li class="nav-item"> <a class="nav-link active" href="parte2_economico.html"> <i class="fas fa-balance-scale fa-fw"></i> Analisi Economica </a> </li>
            <li class="nav-item"> <a class="nav-link" href="parte3_patrimoniale.html"> <i class="fas fa-landmark fa-fw"></i> Analisi Patrimoniale </a> </li>
            <li class="nav-item"> <a class="nav-link" href="parte4_bancabilita.html"> <i class="fas fa-university fa-fw"></i> Bancabilità </a> </li>
            <li class="nav-item"> <a class="nav-link" href="parte5_circolante_flussi.html"> <i class="fas fa-sync-alt fa-fw"></i> Circolante e Flussi </a> </li>
            <li class="nav-item"> <a class="nav-link" href="parte6_rischi-raccomandazioni.html"> <i class="fas fa-exclamation-triangle fa-fw"></i> Rischi e Azioni </a> </li>
            <li class="nav-title">Approfondimenti</li>
            <li class="nav-item"> <a class="nav-link" href="irp_dettaglio.html"> <i class="fas fa-shield-alt fa-fw"></i> Dettaglio IRP </a> </li>
        </ul>
        <div class="sidebar-footer"> <small>SCAN360 © <span id="currentYearSidebar"></span> Kitzanos</small> </div>
    </aside>


    <!-- Contenuto Principale Wrapper -->
    <div class="main-wrapper">
        <!-- Header Orizzontale -->
        <header class="dashboard-header no-print">
            <div class="header-title">
                <h5 class="mb-0">Report Dettagliato: Analisi Economica e Benchmark</h5>
                <p class="mb-0">FLC HEALTHY EVOLUTION S.R.L. | <span class="report-date">31 Dicembre 2024</span></p>
            </div>
            <div class="header-controls d-flex align-items-center">
                <span id="irp-header-badge" class="badge me-3"></span>
                <button class="btn btn-sm btn-outline-secondary me-2 print-button" onclick="printDocument()"> <i class="fas fa-print"></i> Stampa </button>
                <div class="dropdown">
                    <button class="btn btn-sm btn-light border dropdown-toggle" type="button" id="userMenuButton" data-bs-toggle="dropdown" aria-expanded="false"> <i class="fas fa-user-circle me-1"></i> FLC HEALTHY EVOLUTION S.R.L. </button>
                    <ul class="dropdown-menu dropdown-menu-end" aria-labelledby="userMenuButton"> <li><button class="dropdown-item" type="button" onclick="logout()"><i class="fas fa-sign-out-alt me-2"></i>Logout</button></li> </ul>
                </div>
            </div>
        </header>
        <div class="container d-none d-print-block mt-4 mb-4">
            <h1 class="text-center mb-0"><span class="company-name">FLC HEALTHY EVOLUTION S.R.L.</span></h1>
            <p class="text-center mb-0">Report Dettagliato: Analisi Economica e Benchmark | <span class="report-date">31 Dicembre 2024</span></p>
            <hr>
        </div>

        <!-- Area Contenuto Specifico del Report -->
        <div class="dashboard-container">

            <h2 class="section-title" id="economic-analysis"><i class="fas fa-balance-scale me-2"></i>SEZIONE 2.1: ANALISI ECONOMICA</h2>

            <div class="card mb-4 report-section">
                <div class="card-header"><h5 class="mb-0">2.1.1 Conto Economico Riclassificato</h5></div>
                <div class="card-body">
                    <p>Il conto economico riclassificato evidenzia la struttura dei costi e dei ricavi di FLC HEALTHY EVOLUTION S.R.L. nel periodo 2022-2024, consentendo di valutare la redditività operativa e netta.</p>

                     <h6 class="mt-4 text-center small">Grafico 2.1: Andamento Ricavi ed EBITDA 2022-2024 (€000 e %)</h6>
                     <div class="chart-container mb-4" style="height: 350px;">
                         <canvas id="economicTrendChart"></canvas>
                     </div>

                    <h6 class="mt-4">Tabella 2.1: Conto Economico Riclassificato 2022-2024 (valori in €)</h6>
                     <div class="table-responsive">
                         <table class="table table-sm table-striped table-hover">
                             <thead class="table-light">
                                 <tr><th>Voce</th><th class="text-end">2022</th><th class="text-end">% Ricavi</th><th class="text-end">2023</th><th class="text-end">% Ricavi</th><th class="text-end">2024</th><th class="text-end">% Ricavi</th><th class="text-end">Var. % 23-24</th></tr>
                             </thead>
                             <tbody>
                                 <tr><td>Ricavi</td><td class="text-end">818.166</td><td class="text-end">100,0%</td><td class="text-end">813.109</td><td class="text-end">100,0%</td><td class="text-end">1.037.515</td><td class="text-end">100,0%</td><td class="text-success">+27,60%</td></tr>
                                 <tr><td>- Acquisti e consumi</td><td class="text-end">-3.697</td><td class="text-end">-0,5%</td><td class="text-end">-2.738</td><td class="text-end">-0,3%</td><td class="text-end">-4.052</td><td class="text-end">-0,4%</td><td class="text-danger">+47,98%</td></tr>
                                 <tr class="table-secondary"><td>= Valore Aggiunto su Consumi</td><td class="text-end">814.469</td><td class="text-end">99,5%</td><td class="text-end">810.371</td><td class="text-end">99,7%</td><td class="text-end">1.033.463</td><td class="text-end">99,6%</td><td class="text-success">+27,54%</td></tr>
                                 <tr><td>- Costi variabili di produzione</td><td class="text-end">-611.900</td><td class="text-end">-74,8%</td><td class="text-end">-636.855</td><td class="text-end">-78,3%</td><td class="text-end">-644.441</td><td class="text-end">-62,1%</td><td class="text-danger">+1,19%</td></tr>
                                 <tr class="table-secondary"><td>= Margine di Contribuzione</td><td class="text-end">202.569</td><td class="text-end">24,8%</td><td class="text-end">173.516</td><td class="text-end">21,3%</td><td class="text-end">389.022</td><td class="text-end">37,5%</td><td class="text-success">+124,20%</td></tr>
                                 <tr><td>- Costi fissi</td><td class="text-end">-47.272</td><td class="text-end">-5,8%</td><td class="text-end">-152.608</td><td class="text-end">-18,8%</td><td class="text-end">-234.362</td><td class="text-end">-22,6%</td><td class="text-danger">+53,58%</td></tr>
                                 <tr class="table-success fw-bold"><td>= EBITDA</td><td class="text-end">155.297</td><td class="text-end">19,0%</td><td class="text-end">20.908</td><td class="text-end">2,6%</td><td class="text-end">154.660</td><td class="text-end">14,9%</td><td class="text-success">+639,72%</td></tr>
                                 <tr><td>- Ammortamenti e svalutazioni</td><td class="text-end">-14.504</td><td class="text-end">-1,8%</td><td class="text-end">-13.781</td><td class="text-end">-1,7%</td><td class="text-end">-13.883</td><td class="text-end">-1,3%</td><td class="text-danger">+0,74%</td></tr>
                                 <tr class="table-secondary"><td>= EBIT</td><td class="text-end">140.793</td><td class="text-end">17,2%</td><td class="text-end">7.127</td><td class="text-end">0,9%</td><td class="text-end">140.777</td><td class="text-end">13,6%</td><td class="text-success">+1.876,03%</td></tr>
                                 <tr><td>+/- Saldo Oneri/Ricavi Diversi</td><td class="text-end">-11.906</td><td class="text-end">-1,5%</td><td class="text-end">-13.753</td><td class="text-end">-1,7%</td><td class="text-end">-26.671</td><td class="text-end">-2,6%</td><td class="text-danger">+93,98%</td></tr>
                                 <tr class="table-secondary"><td>= Margine Ante Gestione Fin.</td><td class="text-end">128.887</td><td class="text-end">15,8%</td><td class="text-end">-6.626</td><td class="text-end">-0,8%</td><td class="text-end">114.106</td><td class="text-end">11,0%</td><td class="text-success">-1.822,61%</td></tr>
                                 <tr><td>+/- Gestione Finanziaria</td><td class="text-end">-1.013</td><td class="text-end">-0,1%</td><td class="text-end">37.824</td><td class="text-end">4,7%</td><td class="text-end">38.417</td><td class="text-end">3,7%</td><td class="text-success">+1,57%</td></tr>
                                 <tr class="table-secondary"><td>= Risultato Ante Imposte (EBT)</td><td class="text-end">127.874</td><td class="text-end">15,6%</td><td class="text-end">31.198</td><td class="text-end">3,8%</td><td class="text-end">152.523</td><td class="text-end">14,7%</td><td class="text-success">+388,92%</td></tr>
                                 <tr><td>- Imposte</td><td class="text-end">-36.673</td><td class="text-end">-4,5%</td><td class="text-end">-10.986</td><td class="text-end">-1,4%</td><td class="text-end">-14.368</td><td class="text-end">-1,4%</td><td class="text-danger">+30,78%</td></tr>
                                 <tr class="table-success fw-bold"><td>= Utile/Perdita di esercizio</td><td class="text-end">91.201</td><td class="text-end">11,1%</td><td class="text-end">20.212</td><td class="text-end">2,5%</td><td class="text-end">138.155</td><td class="text-end">13,3%</td><td class="text-success">+583,73%</td></tr>
                             </tbody>
                         </table>
                     </div>

                    <h6 class="mt-4">Analisi del Conto Economico (FLC HEALTHY EVOLUTION):</h6>
                    <ol class="small">
                        <li><strong>Ricavi:</strong> Forte crescita (+27,60%) nel 2024 dopo un periodo di stabilità, evidenziando un'accelerazione commerciale significativa.</li>
                        <li><strong>Margine di Contribuzione:</strong> Incremento straordinario (+124,20%) dal 21,3% al 37,5%, indicando una riqualificazione del mix di offerta verso segmenti a maggiore marginalità.</li>
                        <li><strong>EBITDA:</strong> Recupero eccezionale (+639,72%) dopo il minimo del 2023, tornando a livelli di marginalità operativa significativi (14,9%).</li>
                        <li><strong>Costi Fissi:</strong> Incremento significativo (+53,58%) coerente con investimenti strutturali per supportare la crescita dimensionale.</li>
                        <li><strong>Gestione Finanziaria:</strong> Contributo positivo (3,7% dei ricavi) principalmente da proventi da controllate.</li>
                        <li><strong>Utile Netto:</strong> Crescita straordinaria (+583,73%) con un'incidenza sui ricavi del 13,3%, evidenziando un'eccellente redditività complessiva.</li>
                    </ol>
                </div>
            </div>

            <div class="card mb-4 report-section">
                <div class="card-header"><h5 class="mb-0">2.1.2 Analisi della Marginalità</h5></div>
                 <div class="card-body">
                    <p>L'analisi della marginalità valuta la capacità di generare valore aggiunto.</p>
                    <div class="row">
                        <div class="col-lg-7 mb-3 mb-lg-0">
                            <h6 class="text-center small">Grafico 2.2: Evoluzione delle Principali Marginalità (%)</h6>
                             <div class="chart-container" style="height: 350px;">
                                 <canvas id="marginalityChart"></canvas>
                             </div>
                        </div>
                         <div class="col-lg-5">
                             <h6>Tabella 2.2: Evoluzione Indici di Marginalità (FLC HEALTHY EVOLUTION)</h6>
                             <div class="table-responsive">
                                <table class="table table-sm table-striped table-hover">
                                     <thead><tr><th>Indicatore</th><th class="text-end">2022</th><th class="text-end">2023</th><th class="text-end">2024</th><th>Trend</th></tr></thead>
                                     <tbody>
                                         <tr><td>Valore Aggiunto/Ricavi</td><td class="text-end">99,5%</td><td class="text-end">99,7%</td><td class="text-end">99,6%</td><td class="text-secondary"><i class="fas fa-equals"></i></td></tr>
                                         <tr><td>MdC/Ricavi</td><td class="text-end">24,8%</td><td class="text-end">21,3%</td><td class="text-end">37,5%</td><td class="text-success"><i class="fas fa-arrow-up"></i></td></tr>
                                         <tr><td>EBITDA/Ricavi</td><td class="text-end">19,0%</td><td class="text-end">2,6%</td><td class="text-end">14,9%</td><td class="text-success"><i class="fas fa-arrow-up"></i></td></tr>
                                         <tr><td>ROS (EBIT/Ricavi)</td><td class="text-end">17,2%</td><td class="text-end">0,9%</td><td class="text-end">13,6%</td><td class="text-success"><i class="fas fa-arrow-up"></i></td></tr>
                                         <tr><td>Utile Netto/Ricavi</td><td class="text-end">11,1%</td><td class="text-end">2,5%</td><td class="text-end">13,3%</td><td class="text-success"><i class="fas fa-arrow-up"></i></td></tr>
                                         <tr class="table-secondary"><td>Break-Even Point (€)</td><td class="text-end">326.189</td><td class="text-end">779.646</td><td class="text-end">662.065</td><td><i class="fas fa-check text-success"></i></td></tr>
                                         <tr class="table-secondary"><td>Margine Sicurezza</td><td class="text-end">60,1%</td><td class="text-end">4,1%</td><td class="text-end">36,2%</td><td><i class="fas fa-check text-success"></i></td></tr>
                                     </tbody>
                                 </table>
                             </div>
                             <h6 class="mt-3">Break-Even e Leva Operativa (2024 - FLC HEALTHY EVOLUTION)</h6>
                             <div class="alert-box alert-info small mt-2 p-2">
                                 <ul class="list-unstyled mb-0">
                                     <li><i class="fas fa-bullseye me-1"></i> BEP: €662.065 | Margine Sicurezza: 36,2% (Buono)</li>
                                     <li><i class="fas fa-calculator me-1"></i> Moltiplicatore CF: 2,67</li>
                                     <li><i class="fas fa-arrows-alt-v me-1"></i> Resistenza Calo Ricavi: -36,2% | Aumento CF: +60,1%</li>
                                 </ul>
                             </div>
                         </div>
                     </div>
                 </div>
            </div>

            <div class="card mb-4 report-section">
                 <div class="card-header"><h5 class="mb-0">2.1.3 Struttura e Dettaglio Principali Costi</h5></div>
                 <div class="card-body">
                     <p>Analisi delle principali voci di costo e loro incidenza.</p>
                     <h6 class="mt-4">Tabella 2.3: Struttura dei Costi 2023-2024 (FLC HEALTHY EVOLUTION)</h6>
                      <div class="table-responsive">
                         <table class="table table-sm table-striped table-hover">
                            <thead class="table-light">
                                <tr><th>Categoria di Costo</th><th class="text-end">2023 (€)</th><th class="text-end">% Ricavi</th><th class="text-end">2024 (€)</th><th class="text-end">% Ricavi</th><th>Var%</th><th>Benchmark</th><th>Valutazione</th></tr>
                            </thead>
                            <tbody>
                                <tr><td>Acquisti e consumi</td><td class="text-end">2.738</td><td class="text-end">0,3%</td><td class="text-end">4.052</td><td class="text-end">0,4%</td><td class="text-danger">+47,98%</td><td>2-5%</td><td><span class="status-badge bg-success">Efficiente</span></td></tr>
                                <tr><td>Costi variabili prod.</td><td class="text-end">636.855</td><td class="text-end">78,3%</td><td class="text-end">644.441</td><td class="text-end">62,1%</td><td class="text-danger">+1,19%</td><td>60-70%</td><td><span class="status-badge bg-success">Migliorato</span></td></tr>
                                <tr><td>Costo del personale</td><td class="text-end">117.347</td><td class="text-end">14,4%</td><td class="text-end">177.121</td><td class="text-end">17,1%</td><td class="text-danger">+50,95%</td><td>15-20%</td><td><span class="status-badge bg-secondary">In linea</span></td></tr>
                                <tr><td>Godimento beni terzi</td><td class="text-end">35.261</td><td class="text-end">4,3%</td><td class="text-end">57.241</td><td class="text-end">5,5%</td><td class="text-danger">+62,35%</td><td>3-6%</td><td><span class="status-badge bg-secondary">In linea</span></td></tr>
                                <tr><td>Ammortamenti</td><td class="text-end">13.781</td><td class="text-end">1,7%</td><td class="text-end">13.883</td><td class="text-end">1,3%</td><td class="text-danger">+0,74%</td><td>2-4%</td><td><span class="status-badge bg-success">Efficiente</span></td></tr>
                                <tr><td>Oneri diversi</td><td class="text-end">14.840</td><td class="text-end">1,8%</td><td class="text-end">27.751</td><td class="text-end">2,7%</td><td class="text-danger">+87,03%</td><td>1-2%</td><td><span class="status-badge bg-warning">Monitorare</span></td></tr>
                                <tr><td>Oneri finanziari</td><td class="text-end">1.109</td><td class="text-end">0,1%</td><td class="text-end">127</td><td class="text-end">0,01%</td><td class="text-success">-88,55%</td><td>0,5-1,5%</td><td><span class="status-badge bg-success">Molto Basso</span></td></tr>
                            </tbody>
                         </table>
                     </div>
                     <h6 class="mt-4">Approfondimento (FLC HEALTHY EVOLUTION):</h6>
                     <ul class="small">
                          <li><strong>Costi variabili (62,1%):</strong> Significativa riduzione dell'incidenza (-16,2 p.p.) nonostante l'incremento assoluto, evidenziando economie di scala.</li>
                          <li><strong>Personale (17,1%):</strong> Incremento significativo (+50,95%) correlato al potenziamento organico, con produttività per addetto migliorata da €135.518 a €207.503 (+53,1%).</li>
                          <li><strong>Godimento beni terzi (5,5%):</strong> Aumento (+62,35%) coerente con strategia di flessibilizzazione degli asset attraverso contratti di locazione operativa.</li>
                          <li><strong>Oneri diversi (2,7%):</strong> Incremento significativo (+87,03%) da monitorare per possibili inefficienze.</li>
                          <li><strong>Oneri finanziari (0,01%):</strong> Drastica riduzione (-88,55%) conferma la solida gestione finanziaria e la minimizzazione del ricorso al credito oneroso.</li>
                     </ul>
                 </div>
            </div>

            <div class="card mb-4 report-section">
                <div class="card-header"><h5 class="mb-0">2.1.4 Indici di Redditività</h5></div>
                 <div class="card-body">
                     <p>Analisi della capacità di generare ritorni adeguati.</p>
                      <div class="row">
                         <div class="col-lg-7 mb-3 mb-lg-0">
                             <h6>Tabella 2.4: Indici di Redditività 2022-2024 (FLC HEALTHY EVOLUTION)</h6>
                              <div class="table-responsive">
                                 <table class="table table-sm table-striped table-hover">
                                     <thead class="table-light"><tr><th>Indice</th><th>Formula</th><th class="text-end">2022</th><th class="text-end">2023</th><th class="text-end">2024</th><th>Soglia</th><th>Valutazione</th></tr></thead>
                                     <tbody>
                                         <tr><td>ROE</td><td>Utile/PN</td><td class="text-end">14,05%</td><td class="text-end">3,02%</td><td class="text-end">17,79%</td><td>>10%</td><td><span class="status-badge bg-success">Ottimo</span></td></tr>
                                         <tr><td>ROI</td><td>EBIT/CIN</td><td class="text-end">25,16%</td><td class="text-end">1,17%</td><td class="text-end">20,81%</td><td>>8-12%</td><td><span class="status-badge bg-success">Eccellente</span></td></tr>
                                         <tr><td>ROS</td><td>EBIT/Ricavi</td><td class="text-end">17,2%</td><td class="text-end">0,9%</td><td class="text-end">13,6%</td><td>>5-8%</td><td><span class="status-badge bg-success">Eccellente</span></td></tr>
                                         <tr><td>EBITDA Margin</td><td>EBITDA/Ricavi</td><td class="text-end">19,0%</td><td class="text-end">2,6%</td><td class="text-end">14,9%</td><td>>10-12%</td><td><span class="status-badge bg-success">Ottimo</span></td></tr>
                                         <tr><td>Utile Netto/Ricavi</td><td>Utile/Ricavi</td><td class="text-end">11,1%</td><td class="text-end">2,5%</td><td class="text-end">13,3%</td><td>>3-5%</td><td><span class="status-badge bg-success">Eccellente</span></td></tr>
                                         <tr><td>Turnover</td><td>Ricavi/CIN</td><td class="text-end">1,46</td><td class="text-end">1,33</td><td class="text-end">1,53</td><td>>1,2-1,8</td><td><span class="status-badge bg-success">Buono</span></td></tr>
                                     </tbody>
                                 </table>
                             </div>
                         </div>
                          <div class="col-lg-5">
                              <h6 class="text-center small">Grafico 2.3: Andamento Redditività (%)</h6>
                              <div class="chart-container" style="height: 280px;"> <canvas id="profitabilityIndicesChart"></canvas> </div>
                         </div>
                     </div>
                      <h6 class="mt-4">Analisi (FLC HEALTHY EVOLUTION):</h6>
                      <ul class="small">
                          <li><strong>ROE (17,79%):</strong> Eccellente, ben sopra soglia 10% e in forte recupero rispetto al 2023.</li>
                          <li><strong>ROI (20,81%):</strong> Eccellente, più del doppio della soglia ottimale (8-12%), evidenziando un'efficienza superiore nell'utilizzo del capitale investito.</li>
                          <li><strong>ROS (13,6%):</strong> Eccellente, ben sopra soglia 5-8%, indicando un'ottima capacità di generare margini dalle vendite.</li>
                          <li><strong>EBITDA Margin (14,9%):</strong> Ottimo, sopra soglia 10-12% e in forte recupero rispetto al 2023.</li>
                          <li><strong>Turnover (1,53x):</strong> Buono, uso efficiente del capitale con miglioramento rispetto al 2023.</li>
                      </ul>
                 </div>
            </div>

             <div class="card mb-4 report-section">
                <div class="card-header"><h5 class="mb-0">2.1.5 Effetto Leva Finanziaria</h5></div>
                 <div class="card-body">
                     <p>Valutazione dell'impatto dell'indebitamento sulla redditività del capitale proprio.</p>
                      <div class="row">
                          <div class="col-lg-7 mb-3 mb-lg-0">
                              <h6>Tabella 2.5: Analisi Effetto Leva 2022-2024 (FLC HEALTHY EVOLUTION)</h6>
                              <div class="table-responsive">
                                 <table class="table table-sm table-striped table-hover">
                                      <thead><tr><th>Componente</th><th>Formula</th><th class="text-end">2022</th><th class="text-end">2023</th><th class="text-end">2024</th></tr></thead>
                                      <tbody>
                                          <tr><td>ROI</td><td>EBIT/CIN</td><td class="text-end">25,16%</td><td class="text-end">1,17%</td><td class="text-end">20,81%</td></tr>
                                          <tr><td>Costo medio debito (i)</td><td>Oneri Fin./Debiti Fin.</td><td class="text-end">2,60%</td><td class="text-end">8,84%</td><td class="text-end">6,35%</td></tr>
                                          <tr><td>Rapporto D/E</td><td>Debiti Fin./PN</td><td class="text-end">0,005</td><td class="text-end">0,019</td><td class="text-end">0,000</td></tr>
                                          <tr class="table-secondary"><td>Spread (ROI-i)</td><td>ROI - i</td><td class="text-end text-success">22,56%</td><td class="text-end text-danger">-7,67%</td><td class="text-end text-success">14,46%</td></tr>
                                          <tr class="table-secondary"><td>Effetto Leva</td><td>(ROI-i) × D/E</td><td class="text-end text-success">0,11%</td><td class="text-end text-danger">-0,15%</td><td class="text-end text-success">0,00%</td></tr>
                                          <tr><td>ROE calcolato</td><td>ROI + Effetto Leva</td><td class="text-end">25,27%</td><td class="text-end">1,02%</td><td class="text-end">20,81%</td></tr>
                                          <tr class="fw-bold"><td>ROE effettivo</td><td>Utile Netto/PN</td><td class="text-end">14,05%</td><td class="text-end">3,02%</td><td class="text-end">17,79%</td></tr>
                                      </tbody>
                                 </table>
                              </div>
                          </div>
                          <div class="col-lg-5">
                               <h6 class="text-center small">Grafico 2.4: Confronto ROI vs ROE (%)</h6>
                               <div class="chart-container" style="height: 250px;"> <canvas id="leverageChart"></canvas> </div>
                                <h6 class="mt-4">Analisi Leva (FLC HEALTHY EVOLUTION):</h6>
                               <ul class="small list-unstyled">
                                   <li><i class="fas fa-check-circle text-success me-1"></i> Spread (ROI-i) ampiamente positivo (14,46%).</li>
                                   <li><i class="fas fa-check-circle text-success me-1"></i> Effetto Leva nullo (0,00%) per assenza di indebitamento.</li>
                                   <li><i class="fas fa-arrow-down text-success me-1"></i> Leva D/E nulla (0,000x - Ottimo per solidità).</li>
                                   <li><i class="fas fa-info-circle text-info me-1"></i> Potenziale sottoutilizzo della leva finanziaria con spread positivo.</li>
                                   <li><i class="fas fa-question-circle text-info me-1"></i> ROE Effettivo < Teorico (probabile impatto positivo gestione finanziaria).</li>
                               </ul>
                          </div>
                      </div>
                 </div>
            </div>

             <h2 class="section-title mt-5" id="benchmark"><i class="fas fa-chart-bar me-2"></i>SEZIONE 2.2: BENCHMARK E POSIZIONAMENTO COMPETITIVO</h2>

            <div class="card mb-4 report-section">
                <div class="card-header"><h5 class="mb-0">2.2.1 Posizionamento Competitivo</h5></div>
                 <div class="card-body">
                     <p>Valutazione della performance rispetto al settore "Commercio al dettaglio non specializzato" (ATECO 47.1).</p>
                     <div class="row">
                         <div class="col-lg-7 mb-3 mb-lg-0">
                              <h6 class="text-center small">Grafico 2.5: Posizionamento Competitivo (Base 100 = Media Settore)</h6>
                             <div class="chart-container" style="height: 350px;"> <canvas id="benchmarkRadarChart"></canvas>
                                 <script>
                                     document.addEventListener('DOMContentLoaded', function() {
                                         const ctxBenchmarkRadar = document.getElementById('benchmarkRadarChart');

                                         if (ctxBenchmarkRadar) {
                                             try {
                                                  const benchmarkRadarData = {
                                                     labels: ["Crescita Ricavi", "EBITDA Margin", "ROI", "Turnover", "Costo Personale (inv)", "PFN/EBITDA (inv)", "D/E (inv)"],
                                                     datasets: [
                                                         {
                                                             label: "FLC HEALTHY EVOLUTION S.R.L.",
                                                             data: [325, 149, 208, 115, 88, 500, 500],
                                                             backgroundColor: "rgba(25, 25, 112, 0.3)",
                                                             borderColor: "rgba(25, 25, 112, 1)",
                                                             borderWidth: 2, pointBackgroundColor: "rgba(25, 25, 112, 1)", pointBorderColor: "#fff",
                                                             pointHoverBackgroundColor: "#fff", pointHoverBorderColor: "rgba(25, 25, 112, 1)"
                                                         },
                                                         {
                                                             label: "Media Settore",
                                                             data: [100, 100, 100, 100, 100, 100, 100],
                                                             backgroundColor: "rgba(217, 140, 0, 0.3)",
                                                             borderColor: "rgba(217, 140, 0, 1)",
                                                             borderWidth: 2, pointBackgroundColor: "rgba(217, 140, 0, 1)", pointBorderColor: "#fff",
                                                             pointHoverBackgroundColor: "#fff", pointHoverBorderColor: "rgba(217, 140, 0, 1)"
                                                         }
                                                     ]
                                                 };

                                                 const benchmarkRadarOptions = {
                                                     responsive: true,
                                                     maintainAspectRatio: false,
                                                       scales: {
                                                          r: {
                                                              angleLines: { color: '#e0e0e0' }, grid: { color: '#e0e0e0' },
                                                              pointLabels: { font: { size: 10 } },
                                                              ticks: {
                                                                  backdropColor: 'rgba(255, 255, 255, 0.75)', font: { size: 9 },
                                                                  maxTicksLimit: 5,
                                                              },
                                                              suggestedMin: 0,
                                                          }
                                                       },
                                                       plugins: {
                                                            legend: { position: 'bottom', labels: { boxWidth: 12, padding: 15, font: { size: 11 } } },
                                                            title: { display: false },
                                                            tooltip: {
                                                                backgroundColor: 'rgba(0, 0, 0, 0.8)', titleFont: { weight: 'bold', size: 13 },
                                                                bodyFont: { size: 12 }, padding: 10, cornerRadius: 4, displayColors: true, boxPadding: 4,
                                                                callbacks: {
                                                                    label: function(context) {
                                                                        let label = context.dataset.label || '';
                                                                        if (label) label += ': ';
                                                                        if (context.parsed.r !== null) { label += context.parsed.r.toFixed(1); }
                                                                        else { label += 'N/D'; }
                                                                        return label;
                                                                    }
                                                                }
                                                            }
                                                       },
                                                       animation: { duration: 400 }
                                                 };

                                                 const existingChart = Chart.getChart(ctxBenchmarkRadar);
                                                 if (existingChart instanceof Chart) {
                                                     existingChart.destroy();
                                                 }

                                                 new Chart(ctxBenchmarkRadar, {
                                                     type: 'radar',
                                                     data: benchmarkRadarData,
                                                     options: benchmarkRadarOptions
                                                 });
                                                 console.log("Grafico benchmarkRadarChart inizializzato direttamente in HTML.");

                                             } catch (error) {
                                                 console.error("Errore inizializzazione grafico benchmarkRadarChart in HTML:", error);
                                                  const ctx = ctxBenchmarkRadar.getContext('2d');
                                                   if (ctx) {
                                                       ctx.clearRect(0, 0, ctxBenchmarkRadar.width, ctxBenchmarkRadar.height);
                                                       ctx.font = '14px Titillium Web, sans-serif';
                                                       ctx.fillStyle = '#dc3545';
                                                       ctx.textAlign = 'center';
                                                       ctx.fillText('Errore durante il caricamento del grafico.', ctxBenchmarkRadar.width / 2, ctxBenchmarkRadar.height / 2);
                                                   }
                                             }
                                         } else {
                                              console.warn("Canvas 'benchmarkRadarChart' non trovato.");
                                         }
                                     });
                                 </script>
                             </div>
                         </div>
                         <div class="col-lg-5">
                              <h6>Tabella 2.6: Posizionamento Competitivo 2024 (FLC HEALTHY EVOLUTION)</h6>
                              <div class="table-responsive">
                                <table class="table table-sm table-striped table-hover">
                                    <thead><tr><th>Indicatore</th><th>FLC</th><th>Media Sett.</th><th>Gap</th><th>Valutazione</th></tr></thead>
                                    <tbody>
                                        <tr><td>Crescita ricavi</td><td>+27,6%</td><td>+8,5%</td><td class="text-success">+19,1 p.p.</td><td><span class="status-badge bg-success">Eccellente</span></td></tr>
                                        <tr><td>EBITDA Margin</td><td>14,9%</td><td>8-12%</td><td class="text-success">+4,9 p.p.</td><td><span class="status-badge bg-success">Superiore</span></td></tr>
                                        <tr><td>ROI</td><td>20,8%</td><td>10-15%</td><td class="text-success">+8,3 p.p.</td><td><span class="status-badge bg-success">Eccellente</span></td></tr>
                                        <tr><td>ROE</td><td>17,8%</td><td>12,5%</td><td class="text-success">+5,3 p.p.</td><td><span class="status-badge bg-success">Eccellente</span></td></tr>
                                        <tr><td>Turnover</td><td>1,53x</td><td>~1,2-1,5x</td><td class="text-success">+0,18x</td><td><span class="status-badge bg-success">Buono</span></td></tr>
                                        <tr><td>Leva D/E</td><td>0,00x</td><td>0,3-0,6x</td><td class="text-success">-0,45x</td><td><span class="status-badge bg-success">Migliore</span></td></tr>
                                        <tr><td>Ciclo Circolante</td><td>19 gg</td><td>~45-60 gg</td><td class="text-success">-36 gg</td><td><span class="status-badge bg-success">Eccellente</span></td></tr>
                                        <tr><td>PFN/EBITDA</td><td>-0,65x</td><td>~1,0-2,0x</td><td class="text-success">-2,15x</td><td><span class="status-badge bg-success">Eccellente</span></td></tr>
                                    </tbody>
                                </table>
                              </div>
                         </div>
                     </div>
                      <h6 class="mt-4">Analisi posizionamento (FLC HEALTHY EVOLUTION):</h6>
                      <p class="small mb-0">FLC HEALTHY EVOLUTION S.R.L. si posiziona <strong>significativamente meglio della media di settore</strong> su tutti gli indicatori chiave. Particolarmente eccellenti sono la crescita dei ricavi (+27,6% vs +8,5% settoriale), la redditività operativa (ROI 20,8% vs 10-15%) e la solidità finanziaria (PFN negativa e D/E nullo). L'unica area di attenzione è rappresentata dai giorni crediti clienti (128 giorni), significativamente superiori alla media settoriale.</p>
                 </div>
            </div>

             <div class="card mb-4 report-section">
                 <div class="card-header"><h5 class="mb-0">2.2.2 Gap Analysis vs Best Practice</h5></div>
                  <div class="card-body">
                     <p>Identificazione aree di miglioramento rispetto alle best practice.</p>
                     <h6 class="mt-4">Tabella 2.7: Gap Analysis 2024 (FLC HEALTHY EVOLUTION)</h6>
                      <div class="table-responsive">
                         <table class="table table-sm table-striped table-hover">
                            <thead class="table-light"> <tr><th>Area</th><th>Indicatore</th><th>Valore Attuale</th><th>Best Practice</th><th>Gap</th><th>Impatto Potenziale</th><th>Priorità</th></tr></thead>
                             <tbody>
                                <tr><td>Gestione Crediti</td><td>DSO (gg)</td><td>128</td><td>60-90</td><td class="text-danger">+38-68 gg</td><td>€109.516 capitale immob.</td><td><span class="status-badge bg-danger">Alta</span></td></tr>
                                <tr><td>Diversificazione</td><td>Concentrazione clienti</td><td>N/D</td><td>Max 15% per cliente</td><td class="text-warning">Da verificare</td><td>Rischio controparte</td><td><span class="status-badge bg-danger">Alta</span></td></tr>
                                <tr><td>Struttura Finanziaria</td><td>D/E</td><td>0,00</td><td>0,3-0,5</td><td class="text-warning">-0,3-0,5</td><td>Sottoutilizzo leva</td><td><span class="status-badge bg-warning text-dark">Media</span></td></tr>
                                <tr><td>Oneri Diversi</td><td>Oneri Div./Ricavi</td><td>2,7%</td><td>1-2%</td><td class="text-danger">+0,7-1,7%</td><td>€7.000-17.000 costi extra</td><td><span class="status-badge bg-warning text-dark">Media</span></td></tr>
                                <tr><td>Distribuzione Dividendi</td><td>Payout ratio</td><td>22,6%</td><td>30-40%</td><td class="text-warning">-7,4-17,4%</td><td>€10.000-24.000 dividendi</td><td><span class="status-badge bg-info text-dark">Bassa</span></td></tr>
                             </tbody>
                         </table>
                     </div>
                  </div>
             </div>

             <div class="card mb-4 report-section">
                 <div class="card-header"><h5 class="mb-0">2.2.3 Azioni di Miglioramento Suggerite</h5></div>
                  <div class="card-body">
                      <h6 class="mt-4">Tabella 2.8: Piano di Azione Economico (Sintesi - FLC HEALTHY EVOLUTION)</h6>
                      <div class="table-responsive">
                          <table class="table table-sm table-hover action-table">
                              <thead class="table-light"><tr><th><i class="fas fa-flag me-1"></i> Area</th><th><i class="fas fa-wrench me-1"></i> Azione Suggerita</th><th><i class="fas fa-chart-line me-1"></i> Effetti Previsti</th><th><i class="fas fa-coins me-1"></i> Net Benefit Stimato</th></tr></thead>
                              <tbody>
                                  <tr><td>Credit Management</td><td>Implementazione sistema credit scoring + factoring selettivo</td><td>Riduzione DSO a 90 giorni</td><td class="text-success">€109.516 liquidità</td></tr>
                                  <tr><td>Diversificazione</td><td>Analisi portafoglio clienti e strategia acquisizione</td><td>Riduzione rischio controparte</td><td class="text-success">Mitigazione rischio</td></tr>
                                  <tr><td>Struttura Finanziaria</td><td>Valutazione leva finanziaria ottimale</td><td>Incremento ROE</td><td class="text-success">+2-3% ROE</td></tr>
                                  <tr><td>Oneri Diversi</td><td>Audit processi amministrativi</td><td>Riduzione incidenza 0,8%</td><td class="text-success">€8.300 EBITDA</td></tr>
                                  <tr><td>Ottimizzazione Fiscale</td><td>Implementazione holding strutturata</td><td>Risparmio fiscale 3-5%</td><td class="text-success">€4.300-7.200 Utile</td></tr>
                              </tbody>
                          </table>
                      </div>
                       <p class="small mt-3 text-muted">L'implementazione di queste azioni potrebbe migliorare l'EBITDA di ~€8.300, liberare €109.516 di liquidità e ottimizzare la struttura finanziaria.</p>
                  </div>
             </div>

            <div class="card summary-card mb-4 report-section">
                <div class="card-body">
                    <h5 class="card-title"><i class="fas fa-check-circle text-primary me-2"></i>Conclusioni Analisi Economica e Benchmark (FLC HEALTHY EVOLUTION)</h5>
                     <p>FLC HEALTHY EVOLUTION S.R.L. presenta un <strong>eccellente profilo di redditività</strong>, nettamente superiore ai benchmark di settore, con una crescita robusta e una solidità finanziaria straordinaria. La <strong>principale area di intervento</strong> riguarda la <strong>gestione dei crediti commerciali</strong> (DSO 128 giorni), che rappresenta l'unica criticità significativa in un quadro altrimenti eccellente.</p>
                     <p>La robusta generazione di cassa, l'assenza di indebitamento e l'elevata marginalità offrono ampi margini per finanziare strategie di sviluppo (organico o M&A), ottimizzare la struttura finanziaria e migliorare ulteriormente le performance già eccellenti.</p>
                </div>
            </div>

        </div> <!-- /dashboard-container -->

        <!-- Footer Standard V2 (Nessuna modifica necessaria) -->
        <footer class="footer no-print"> <div class="container-fluid px-4"> <div class="row align-items-center"> <div class="col-md-6 text-center text-md-start mb-2 mb-md-0"> SCAN360 © <span id="currentYearFooterReport"></span> </div> <div class="col-md-6 text-center text-md-end"> Powered by <a href="http://www.kitzanos.com" target="_blank" class="text-white fw-bold">Kitzanos Lab</a> <img src="../assets/img/logo_kitzanos.png" alt="Kitzanos Logo" class="ms-2"> </div> </div> </div> </footer>

    </div> <!-- /main-wrapper -->

    <!-- Script JS -->
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.3.0/js/bootstrap.bundle.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/Chart.js/3.9.1/chart.min.js"></script>
    <script src="../js/common.js"></script>
    <script src="../js/charts_config.js"></script>
    <script src="../js/report_init.js"></script>
     <script>
        document.getElementById('currentYearSidebar').textContent = new Date().getFullYear();
        document.getElementById('currentYearFooterReport').textContent = new Date().getFullYear();

         document.addEventListener('DOMContentLoaded', function() {
             const irpScoreValue = 87.25;
             const irpHeaderBadge = document.getElementById('irp-header-badge');
             if(irpHeaderBadge) {
                 let badgeClass = 'bg-warning text-dark';
                 if (irpScoreValue >= 71) badgeClass = 'bg-success';
                 else if (irpScoreValue < 51) badgeClass = 'bg-danger';
                 irpHeaderBadge.className = `badge ${badgeClass} me-3`;
                 irpHeaderBadge.textContent = `IRP: ${irpScoreValue.toFixed(1)}`;
             }

             if (typeof logout !== 'function') {
                 window.logout = function() {
                    console.log("Logout action triggered (placeholder)");
                }
             }
             if (typeof printDocument !== 'function') {
                window.printDocument = function() {
                    window.print();
                }
             }
         });
   </script>

<scan-chat data-bot-id="44479c6e-7072-49fc-9046-e650ff6f9874"></scan-chat>
<script src="../js/bundle.js"></script>
</body>
</html>